|
|
557 * !
|
Wed, 7/31/2019,
2:00 PM -
3:50 PM
|
CC-108
|
Data Monitoring Committees – the Multi-Disciplinary Approach to Drug Safety Assessment — Topic Contributed Papers
|
Biopharmaceutical Section, International Indian Statistical Association, Section for Statistical Programmers and Analysts
|
Organizer(s): Amit Bhattacharyya, Alexion Pharmaceuticals
|
Chair(s): William (Bill) Wang, Merck Research Lab
|
2:05 PM
|
EMERGING CHANGES in DMC OVERSIGHT
Susan S. Ellenberg, University of Pennsylvania
|
2:25 PM
|
A Journey Through Guidelines for DMC in Addressing Evolving Paradigm Changes – What Really Matters
Estelle Russek-Cohen, FDA CDER
|
2:45 PM
|
The Perfect DMC – a Multi-Disciplinary Approach to Monitor Patient Safety:
Jonathan Seltzer, ACI Clinical
|
3:05 PM
|
Implementing Effective DMC Decision-Making in Complex Clinical Trial Designs
Paul Gallo, Novartis Pharmaceutical
|
3:25 PM
|
Are Interactive Graphics in a DMC Ready for Prime-Time, for Better Safety Reviews?
James Buchanan, Covilance LLC
|
3:45 PM
|
Floor Discussion
|